Business Description
Advanced Medical Solutions Group PLC
ISIN : GB0004536594
Total Employee Number:
1,658Description
Advanced Medical Solutions Group PLC is engaged in developing and manufacturing wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical and Woundcare, of which the Surgical segment derives maximum revenue. Geographically, the company operates in the United Kingdom, Germany, France, the rest of Europe, the United States of America, and the rest of the world.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.22 | |||||
Equity-to-Asset | 0.66 | |||||
Debt-to-Equity | 0.32 | |||||
Debt-to-EBITDA | 1.85 | |||||
Interest Coverage | 5.93 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.02 | |||||
Beneish M-Score | -2.82 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 22.5 | |||||
3-Year EBITDA Growth Rate | 7.7 | |||||
3-Year EPS without NRI Growth Rate | 3.7 | |||||
3-Year FCF Growth Rate | 5.7 | |||||
3-Year Book Growth Rate | 3.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 21.17 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 7.63 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 91.09 | |||||
9-Day RSI | 83.73 | |||||
14-Day RSI | 76.24 | |||||
3-1 Month Momentum % | 15.15 | |||||
6-1 Month Momentum % | 2.76 | |||||
12-1 Month Momentum % | 3.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.79 | |||||
Quick Ratio | 1.39 | |||||
Cash Ratio | 0.36 | |||||
Days Inventory | 213.4 | |||||
Days Sales Outstanding | 71.46 | |||||
Days Payable | 68.21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.03 | |||||
Dividend Payout Ratio | 0.08 | |||||
3-Year Dividend Growth Rate | 10.5 | |||||
Forward Dividend Yield % | 1.03 | |||||
5-Year Yield-on-Cost % | 1.95 | |||||
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 2.31 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 53.35 | |||||
Operating Margin % | 12.43 | |||||
Net Margin % | 4.35 | |||||
EBITDA Margin % | 19.21 | |||||
FCF Margin % | 8.73 | |||||
OCF Margin % | 14.23 | |||||
ROE % | 3.95 | |||||
ROA % | 2.53 | |||||
ROIC % | 4.66 | |||||
3-Year ROIIC % | -2.08 | |||||
ROC (Joel Greenblatt) % | 18.23 | |||||
ROCE % | 6.52 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 60.89 | |||||
Forward PE Ratio | 17.9 | |||||
PE Ratio without NRI | 23.22 | |||||
Shiller PE Ratio | 27.17 | |||||
Price-to-Owner-Earnings | 33.8 | |||||
PEG Ratio | 1.73 | |||||
PS Ratio | 2.64 | |||||
PB Ratio | 2.29 | |||||
Price-to-Tangible-Book | 11.12 | |||||
Price-to-Free-Cash-Flow | 30.11 | |||||
Price-to-Operating-Cash-Flow | 18.52 | |||||
EV-to-EBIT | 29.66 | |||||
EV-to-EBITDA | 15.23 | |||||
EV-to-Forward-EBITDA | 13.12 | |||||
EV-to-Revenue | 2.93 | |||||
EV-to-Forward-Revenue | 2.73 | |||||
EV-to-FCF | 29.33 | |||||
Price-to-GF-Value | 0.75 | |||||
Price-to-Projected-FCF | 1.39 | |||||
Price-to-Median-PS-Value | 0.47 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.76 | |||||
Price-to-Graham-Number | 3.39 | |||||
| Price-to-Net-Current-Asset-Value | 139 | |||||
Earnings Yield (Greenblatt) % | 3.37 | |||||
FCF Yield % | 3.3 | |||||
Forward Rate of Return (Yacktman) % | 16.24 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Advanced Medical Solutions Group PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 228.936 | ||
| EPS (TTM) (£) | 0.045 | ||
| Beta | -0.3245 | ||
| 3-Year Sharpe Ratio | -0.46 | ||
| 3-Year Sortino Ratio | -0.52 | ||
| Volatility % | 34.48 | ||
| 14-Day RSI | 76.24 | ||
| 14-Day ATR (£) | 0.102371 | ||
| 20-Day SMA (£) | 2.258125 | ||
| 12-1 Month Momentum % | 3.47 | ||
| 52-Week Range (£) | 1.872 - 2.79 | ||
| Shares Outstanding (Mil) | 217.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Advanced Medical Solutions Group PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Advanced Medical Solutions Group PLC Stock Events
| Event | Date | Price (£) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2026 | 2026-09-17 13:30 | In 84 days | ||
| Second quarter earnings results for 2026 | 2026-09-17 | In 83 days | ||
| General meeting for 2025 | 2026-06-17 10:00 | 2.15 (+0.47%) | ||
| GBP 0.020100 Cash Dividend | 2026-05-28 | 2.19 (+1.04%) | ||
| Annual report for 2025 | 2026-05-15 | 2.54 (+2.01%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-18 | 1.99 (+3.65%) | ||
| GBP 0.008500 Cash Dividend | 2025-09-25 | 2.22 (+3.02%) | ||
| Second quarter earnings conference call for 2025 | 2025-09-17 13:30 | 2.07 (+0.24%) | ||
| Second quarter earnings results for 2025 | 2025-09-17 | 2.07 (+0.24%) | ||
| General meeting for 2024 | 2025-06-30 11:00 | 2.15 (-0.58%) |
Show
Entries
Advanced Medical Solutions Group PLC Frequently Asked Questions
What is Advanced Medical Solutions Group PLC(CHIX:AMSl)'s stock price today?
The current price of CHIX:AMSl is £2.78. The 52 week high of CHIX:AMSl is £2.79 and 52 week low is £1.87.
When is next earnings date of Advanced Medical Solutions Group PLC(CHIX:AMSl)?
The next earnings date of Advanced Medical Solutions Group PLC(CHIX:AMSl) is 2026-09-17 Est..
Does Advanced Medical Solutions Group PLC(CHIX:AMSl) pay dividends? If so, how much?
The Dividend Yield %  of Advanced Medical Solutions Group PLC(CHIX:AMSl) is 1.03% (As of Today), Highest Dividend Payout Ratio of Advanced Medical Solutions Group PLC(CHIX:AMSl) was 0.3. The lowest was 0.08. And the median was 0.19. The  Forward Dividend Yield % of Advanced Medical Solutions Group PLC(CHIX:AMSl) is 1.03%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Advanced Medical Solutions Group PLC
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers